Progress in targeted therapy for breast cancer
Breast cancer is a multistep, multifactorial, and heterogeneous disease. Significant transformations have occurred in the systemic management of breast cancer in the past decade. Due to the further understanding of pathogenesis, scientists have found plenty of signaling pathways and correspondingly...
Guardado en:
Autores principales: | Jie Ju, An-Jie Zhu, Peng Yuan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a5f812652b04672861ee0071144abcf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting MET in cancer therapy
por: Hong-Nan Mo, et al.
Publicado: (2017) -
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Peng Yuan, et al.
Publicado: (2017) -
HER2 breast cancer therapies: a review
por: Conleth G Murphy, et al.
Publicado: (2009) -
Ovarian cancer: emerging molecular-targeted therapies
por: Sourbier C
Publicado: (2012) -
Targeted therapy using nanotechnology: focus on cancer
por: Sanna V, et al.
Publicado: (2014)